Evidence map›Paper›PMID 27596163›Full record

Trial reportBMC pediatrics2016

Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children.

Margery A Connelly, Chisato Shimizu, Deborah A Winegar, Irina Shalaurova, Ray Pourfarzib, James D Otvos, John T Kanegaye, Adriana H Tremoulet, Jane C Burns

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in BMC pediatrics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Glycoprotein Profile Measured by aLife (Basel, Switzerland) · 2021
    Article
  9. Review
  10. Title: Human Serum/Plasma Glycoprotein Analysis byJournal of clinical medicine · 2020
    Review
  11. Article
  12. Article
  13. Observational
  14. Observational
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Margery A ConnellyLipoScience, Laboratory Corporation of America® Holdings, 2500 Sumner Blvd, Raleigh, NC, 27616, USA. connem5@labcorp.com.
Chisato ShimizuDepartment of Pediatrics, University of California, San Diego, CA, USA.
Deborah A WinegarLipoScience, Laboratory Corporation of America® Holdings, 2500 Sumner Blvd, Raleigh, NC, 27616, USA.
Irina ShalaurovaLipoScience, Laboratory Corporation of America® Holdings, 2500 Sumner Blvd, Raleigh, NC, 27616, USA.
Ray PourfarzibLipoScience, Laboratory Corporation of America® Holdings, 2500 Sumner Blvd, Raleigh, NC, 27616, USA.
James D OtvosLipoScience, Laboratory Corporation of America® Holdings, 2500 Sumner Blvd, Raleigh, NC, 27616, USA.
John T KanegayeDepartment of Pediatrics, University of California, San Diego, CA, USA.
Adriana H TremouletDepartment of Pediatrics, University of California, San Diego, CA, USA.
Jane C BurnsDepartment of Pediatrics, University of California, San Diego, CA, USA.
University of California, San Diego · USRady Children's Hospital-San Diego · US

Funding

iDASH: Integrating Data for Analysis, Anonymization, and SharingU54HL108460 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI OHNO-MACHADO, LUCILA · 2010 to 2015
$19.1M
Genetic Markers and gene expression in Kawasaki DiseaseR01HL069413 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BURNS, JANE C · 2002 to 2010
$5.5M
NHLBI NIH HHS R01 HL069413NHLBI NIH HHS U54 HL108460
6 · The paper itself

Abstract

backgroundGlycosylation patterns of serum proteins, such as α1-acid glycoprotein, are modified during an acute phase reaction. The response of acute Kawasaki disease (KD) patients to IVIG treatment has been linked to sialic acid levels on native IgG, suggesting that protein glycosylation patterns vary during the immune response in acute KD. Additionally, the distribution and function of lipoprotein particles are altered during inflammation. Therefore, the aim of this study was to explore the potential for GlycA, a marker of protein glycosylation, and the lipoprotein particle profile to distinguish pediatric patients with acute KD from those with other febrile illnesses.

methodsNuclear magnetic resonance was used to quantify GlycA and lipoprotein particle classes and subclasses in pediatric subjects with acute KD (n = 75), post-treatment subacute (n = 36) and convalescent (n = 63) KD, as well as febrile controls (n = 48), and age-similar healthy controls (n = 48).

resultsGlycA was elevated in acute KD subjects compared to febrile controls with bacterial or viral infections, IVIG-treated subacute and convalescent KD subjects, and healthy children (P <0.0001). Acute KD subjects had increased total and small low density lipoprotein particle numbers (LDL-P) (P <0.0001) and decreased total high density lipoprotein particle number (HDL-P) (P <0.0001) compared to febrile controls. Consequently, the ratio of LDL-P to HDL-P was higher in acute KD subjects than all groups tested (P <0.0001). While GlycA, CRP, erythrocyte sedimentation rate, LDL-P and LDL-P/HDL-P ratio were able to distinguish patients with KD from those with other febrile illnesses (AUC = 0.789-0.884), the combinations of GlycA and LDL-P (AUC = 0.909) or GlycA and the LDL-P/HDL-P ratio (AUC = 0.910) were best at discerning KD in patients 6-10 days after illness onset.

conclusionsHigh levels of GlycA confirm enhanced protein glycosylation as part of the acute phase response in KD patients. When combined with common laboratory tests and clinical characteristics, GlycA and NMR-measured lipoprotein particle parameters may be useful for distinguishing acute KD from bacterial or viral illnesses in pediatric patients.

Indexed as

Acute-Phase ProteinsBiomarkersCase-Control StudiesChildChild, PreschoolCholesterol, HDLCholesterol, LDLDiagnosis, DifferentialFemaleFeverGlycosylationHumansInfantMagnetic Resonance SpectroscopyMaleMucocutaneous Lymph Node SyndromeAcute-Phase ProteinsBiomarkersCholesterol, HDLCholesterol, LDLBiomarkersGlycAKawasaki diseaseLipoprotein particle number

Identifiers

PMID27596163
PMCPMC5011873
OpenAlexW2507632073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.